search
Back to results

Glycemic Index/Saturated Fatty Acid Diet and Hepatic Fat

Primary Purpose

Fatty Liver, Nonalcoholic, Diet, Healthy, Obesity

Status
Completed
Phase
Not Applicable
Locations
Netherlands
Study Type
Interventional
Intervention
High GI/SFA diet
Low GI/SFA diet
Sponsored by
Maastricht University Medical Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Fatty Liver, Nonalcoholic focused on measuring NAFLD, Diet, Glycemic index

Eligibility Criteria

45 Years - 75 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Caucasian
  • Male or postmenopausal female
  • Aged 45-75 years at start of the study
  • Body mass index (BMI) 27 - 38 kg/m2
  • Stable dietary habits (no weight loss or gain >3kg in the past 3 months) Sedentary lifestyle (not more than 2 hours of sports per week)
  • TG between 1.0 and 4.0 mmol/L

Exclusion Criteria:

  • Type 2 diabetes
  • Any acute condition, exacerbation of chronic condition, or medical history that would in the investigator's or dependent physician's opinion interfere with the study
  • Contra-indication for MRI (which can be found in appendix II)
  • Alcohol consumption of >2 servings per day
  • Smoking
  • Use of medication known to interfere with the safety of study procedures

Sites / Locations

  • Maastricht University

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

High GI/SFA diet

Low GI/SFA diet

Arm Description

Subjects will adhere to a two-week high GI and high SFA diet. Crossover design, randomly assigned to start with either high GI/SFA or low GI/SFA. 4 week washout between the two diets.

Subjects will adhere to a two-week low GI and low SFA diet. Crossover design, randomly assigned to start with either high GI/SFA or low GI/SFA. 4 week washout between the two diets.

Outcomes

Primary Outcome Measures

Hepatic fat content
Expressed as a percentage, measured by 1H-MRS

Secondary Outcome Measures

Hepatic De Novo Lipogenesis
Percentage of palmitate in VLDL-TG originating from DNL
Hepatic fat composition (%SFA, MUFA, PUFA)
Measured by 1H-MRS
Hepatic glycogen content
Measured by 13C-MRS

Full Information

First Posted
August 1, 2019
Last Updated
July 14, 2021
Sponsor
Maastricht University Medical Center
Collaborators
Unilever R&D
search

1. Study Identification

Unique Protocol Identification Number
NCT04054297
Brief Title
Glycemic Index/Saturated Fatty Acid Diet and Hepatic Fat
Official Title
The Effect of a Low Compared to a High Glycemic Index/Saturated Fatty Acid Diet on Hepatic Fat
Study Type
Interventional

2. Study Status

Record Verification Date
July 2021
Overall Recruitment Status
Completed
Study Start Date
July 22, 2019 (Actual)
Primary Completion Date
March 23, 2021 (Actual)
Study Completion Date
March 23, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Maastricht University Medical Center
Collaborators
Unilever R&D

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Excessive fat in the liver is associated with impairments in metabolic health. Reducing the amount of carbohydrates and fat both have been shown to reduce liver fat. However, not only the amount fats and carbohydrates, but also their quality have been shown to influence liver fat. Diets high in saturated fatty acids (SFA) and diets with a high glycemic index (GI) have been shown to increase liver fat content. However, available data from human dietary intervention studies is limited and these studies did not reflect a realistic diet. In the present study a combination of low GI/SFA on the one hand and high GI/SFA on the other hand is used to reflect realistically a healthy and an unhealthy diet as they are actually consumed by the Dutch population. The primary objective of this study is to investigate whether a two-week low compared to high GI/SFA diet reduces liver fat content. In addition, it will be investigated whether a two- week low compared to high GI/SFA diet reduces DNL, lowers the 24-hour glycemic response, lowers hepatic glycogen content, increases hepatic fat oxidation and changes hepatic lipid composition. Furthermore, the metabolic response to a meal (metabolites related to energy metabolism and substrate oxidation) will be studied upon the low and high GI/SFA diets.
Detailed Description
Rationale: Excessive fat in the liver is associated with impairments in metabolic health. Reducing the amount of carbohydrates and fat both have been shown to reduce liver fat. However, not only the amount fats and carbohydrates, but also their quality have been shown to influence liver fat. Diets high in saturated fatty acids (SFA) and diets with a high glycemic index (GI) have been shown to increase liver fat content. However, available data from human dietary intervention studies is limited and these studies did not reflect a realistic diet. Here the investigators want to combine low GI/SFA on the one hand and high GI/SFA on the other hand to reflect realistically a healthy and an unhealthy diet as they are actually consumed by the Dutch population. It is hypothesized that such a low compared to a high GI/SFA diet reduces liver fat content and possibly liver fat composition. Furthermore, underlying pathways involved in mediating those changes in liver fat are largely unknown. Hepatic lipid storage can originate from several metabolic pathways, including de novo lipogenesis (DNL) or decreased hepatic fat oxidation. Based on current literature the investigators hypothesize that with the diets chosen here, both DNL (by differences in GI) and fat oxidation (by differences in fat composition) will be involved in causing changes in liver fat. Objective: The primary objective of this study is to investigate whether a two-week low compared to high GI/SFA diet reduces liver fat content. In addition, it will be investigated whether a two- week low compared to high GI/SFA diet reduces DNL, lowers the 24-hour glycemic response, lowers hepatic glycogen content, increases hepatic fat oxidation and changes hepatic lipid composition. Furthermore, the metabolic response to a meal (metabolites related to energy metabolism and substrate oxidation) will be studied upon the low and high GI/SFA diets. Study design: This is a randomized cross-over study comparing the effects of a high GI/SFA compared to a low GI/SFA diet. Study population: Up to seventeen healthy overweight/obese males and postmenopausal females, aged between 45-75 years and BMI between 27-38 kg/m2 will participate in the study (minimally 13 volunteers need to finish the study).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Fatty Liver, Nonalcoholic, Diet, Healthy, Obesity
Keywords
NAFLD, Diet, Glycemic index

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
13 (Actual)

8. Arms, Groups, and Interventions

Arm Title
High GI/SFA diet
Arm Type
Experimental
Arm Description
Subjects will adhere to a two-week high GI and high SFA diet. Crossover design, randomly assigned to start with either high GI/SFA or low GI/SFA. 4 week washout between the two diets.
Arm Title
Low GI/SFA diet
Arm Type
Experimental
Arm Description
Subjects will adhere to a two-week low GI and low SFA diet. Crossover design, randomly assigned to start with either high GI/SFA or low GI/SFA. 4 week washout between the two diets.
Intervention Type
Behavioral
Intervention Name(s)
High GI/SFA diet
Intervention Description
Subject will adhere to a 2 week high GI/SFA diet.
Intervention Type
Behavioral
Intervention Name(s)
Low GI/SFA diet
Intervention Description
Subject will adhere to a 2 week low GI/SFA diet.
Primary Outcome Measure Information:
Title
Hepatic fat content
Description
Expressed as a percentage, measured by 1H-MRS
Time Frame
20 minutes
Secondary Outcome Measure Information:
Title
Hepatic De Novo Lipogenesis
Description
Percentage of palmitate in VLDL-TG originating from DNL
Time Frame
20 hours
Title
Hepatic fat composition (%SFA, MUFA, PUFA)
Description
Measured by 1H-MRS
Time Frame
20 minutes
Title
Hepatic glycogen content
Description
Measured by 13C-MRS
Time Frame
20 minutes

10. Eligibility

Sex
All
Minimum Age & Unit of Time
45 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Caucasian Male or postmenopausal female Aged 45-75 years at start of the study Body mass index (BMI) 27 - 38 kg/m2 Stable dietary habits (no weight loss or gain >3kg in the past 3 months) Sedentary lifestyle (not more than 2 hours of sports per week) TG between 1.0 and 4.0 mmol/L Exclusion Criteria: Type 2 diabetes Any acute condition, exacerbation of chronic condition, or medical history that would in the investigator's or dependent physician's opinion interfere with the study Contra-indication for MRI (which can be found in appendix II) Alcohol consumption of >2 servings per day Smoking Use of medication known to interfere with the safety of study procedures
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Vera Schrauwen-Hinderling, PhD
Organizational Affiliation
Maastricht University Medical Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
Maastricht University
City
Maastricht
ZIP/Postal Code
6229 ER
Country
Netherlands

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Glycemic Index/Saturated Fatty Acid Diet and Hepatic Fat

We'll reach out to this number within 24 hrs